Dorsal raphe vs. median raphe serotonergic antagonism. Anatomical, physiological, behavioral, neuroendocrinological, neuropharmacological and clinical evidences: Relevance for neuropharmacological therapy

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 30, Issue 4, 2006, Pages 565-585

  Lechin, Fuad ^a   van der Dijs, Bertha ^a   Hernández Adrián, Gerardo ^a  

^a UNIVERSIDAD CENTRAL DE VENEZUELA   (Venezuela)

Author keywords

5 HT 1A receptors; 5 HT 1B D receptors; Central serotonergic system; Depression and psychotic circuitries; Dorsal raphe; Major depression and dysthymic depression; Median raphe

Indexed keywords

ADRAFINIL; ADRENALIN; ALNESPIRONE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; CATECHOLAMINE; CHOLINERGIC RECEPTOR; CITALOPRAM; CLOMIPRAMINE; CLONIDINE; DEXAMETHASONE; DOPAMINE; FLUOXETINE; HALOPERIDOL; MODAFINIL; NICOTINIC RECEPTOR; NORADRENALIN; PAROXETINE; PINDOLOL; SEROTONIN; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; SEROTONIN UPTAKE INHIBITOR; SUMATRIPTAN; TIANEPTINE; YOHIMBINE;

AGGRESSION; AKATHISIA; BEHAVIOR; CENTRAL NERVOUS SYSTEM; DEPRESSION; DORSAL RAPHE NUCLEUS; DRUG POTENTIATION; DYSTHYMIA; HUMAN; IMPULSIVENESS; LOCUS CERULEUS; MAJOR DEPRESSION; MEDIAN RAPHE NUCLEUS; MENTAL DISEASE; MODEL; NEUROANATOMY; NEUROCHEMISTRY; NEUROENDOCRINOLOGY; NEUROPHARMACOLOGY; NEUROPHYSIOLOGY; NONHUMAN; PATHOPHYSIOLOGY; POSTSYNAPTIC MEMBRANE; REVIEW; SEROTONINERGIC SYSTEM; SUICIDAL BEHAVIOR;

ANIMALS; BEHAVIOR; CATECHOLAMINES; HUMANS; NEURAL PATHWAYS; NEUROENDOCRINOLOGY; NEUROPHARMACOLOGY; NEUROPHYSIOLOGY; RAPHE NUCLEI; SEROTONIN ANTAGONISTS;

EID: 33646086466     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2005.11.025     Document Type: Review

References (271)

1. Abellan M.T., Jolas T., Aghajanian G.K., and Artigas F. Dual control of dorsal raphe serotonergic neurons by GABA(B) receptors. Electrophysiological and microdialysis studies. Synapse 36 1 (2000) 21-34
2. Adell A., and Artigas F. A microdialysis study of the in vivo release of 5-HT in the median raphe nucleus of the rat. Br J Pharmacol 125 6 (1998) 1361-1367
3. Adell A., and Artigas F. Regulation of the release of 5-hydroxytryptamine in the median raphe nucleus of the rat by catecholaminergic afferents. Eur J Neurosci 11 (1999) 2305-2311
4. Adell A., Celada P., Abellan M.T., and Artigas F. Origin and functional role of the extracellular serotonin in the midbrain raphe nuclei. Brain Res Rev 39 (2002) 154-180
5. Advis J.P., Simpkins J.W., Benney J., and Meites J. Serotonergic control of prolactin release in male rats. Life Sci 24 4 (1979) 359-365
6. Ahlenius S., and Larsson K. Evidence for an involvement of 5-HT1B receptors in the inhibition of male rat ejaculatory behavior produced by 5-HTP. Psychopharmacology 137 4 (1998) 374-382
7. Ahn K.C., Pazderka-Robinson H., Clements R., Ashcroft R., Ali T., Morse C., et al. Differential effects of intra-midbrain raphe and systemic 8-OH-DPAT on VTA self-stimulation thresholds in rats. Psychopharmacology (Berl) 178 4 (2005) 381-388
8. Almiron R.S., and Ramirez O.A. Participation of dorsal raphe nucleus in the behavioral alteration observed after discontinuation of chronic diazepam administration: possible neural circuitry involved. Synapse 56 2 (2005) 61-68
9. Anderson G.M., Segman R.H., and King R.A. Serotonin and suicidality: the impact of fluoxetine administration: II. Acute neurobiological effects. Isr J Psychiatry Relat Sci 32 1 (1995) 44-50
10. Andrade T.G., Macedo C.E., Zangrossi Jr. H., and Graeff F.G. Anxiolytic-like effects of median raphe nucleus lesion in the elevated T-maze. Behav Brain Res 153 (2004) 55-60
11. Arkle M., and Ebenezer I.S. Isapirone suppresses food intake in food-deprived rats by an action at 5-HT-1A receptors. Eur J Pharmacol 408 (2000) 273-276
12. Assie M.B., and Koek W. (-)-Pindolol and (+/-)-tertatolol affect rat hippocampal 5-HT levels through mechanisms involving not only 5-HT1A, but also 5-HT1B receptors. Neuropharmacology 35 2 (1996) 213-222
13. Astier B., Van Bockstaele E.J., Aston-Jones G., and Pieribone V.A. Anatomical evidence for multiple pathways leading from the rostral ventrolateral medulla (nucleus paragigantocellularis) to the locus coeruleus in rat. Neurosci Lett 118 2 (1990) 141-146
14. Attenburrow M.J., Williams C., Odontiadis J., Reed A., Powell J., Cowen P.J., et al. Acute administration of nutritionally sourced tryptophan increases fear recognition. Psychopharmacology 33 (2003) 1381-1386
15. Auerbach S.B., and Hjorth S. Effect of chronic administration of the selective serotonin (5-HT) uptake inhibitor citalopram on extracellular 5-HT and apparent autoreceptor sensitivity in rat forebrain in vivo. Naunyn-Schmiedeberg's Arch Pharmacol 352 (1995) 597-606
16. Azmitia E.C., and Segal M. An autoradiographic analysis of the differential ascending projections of the dorsal and median raphe nuclei in the rat. J Comp Neurol 179 3 (1978) 641-667
17. Bagdy G., Calogero A.E., Szemeredi K., Gomez M.T., Murphy D.L., Chrousos G.P., et al. Beta-endorphin responses to different serotonin agonists: involvement of corticotropin-releasing hormone, vasopresin, and direct pituitary action. Brain Res 537 (1990) 227-232
18. Baraban J.M., and Aghajanian G.K. Suppression of firing activity of 5-HT neurons in the dorsal raphe by alpha-adrenoceptor antagonists. Neuropharmacology 19 4 (1980) 355-363
19. Baraban J.M., and Aghajanian G.K. Noradrenergic innervation of serotonergic neurons in the dorsal raphe: demonstration by electron microscopic autoradiography. Brain Res 204 1 (1981) 1-11
20. Barr G.A., Gibbons J.L., and Bridger W.H. Inhibition of rat predatory aggression by acute and chronic d- and l-amphetamine. Brain Res 124 3 (1977) 565-570
21. Beaulieu S., Di Paolo T., and Barden N. Control of ACTH secretion by the central nucleus of the amygdala: implication of the serotoninergic system and its relevance to the glucocorticoid delayed negative feedback mechanism. Neuroendocrinology 44 (1986) 247-254
22. Bielau H., Mawrin C., Krell D., Agelink M.W., Trubner K., Davis R., et al. Differences in activation of the dorsal raphe nucleus depending on performance of suicide. Brain Res 1039 (2005) 43-52
23. Blier P., Lista A., and De Montigny C. Differential properties of pre- and postsynaptic 5-Hydroxytryptamine-1A receptors in the dorsal raphe and hippocampus: I. Effect of spiperone. J Pharmacol Exp Ther 265 (1993) 7-15
24. Bolaños-Jimenez F., Manhaes de Castro R.M., Seguin L., Cloez-Tayarani I., Monneret V., Drieu K., et al. Effects of stress on the functional properties of pre- and postsynaptic 5-HT1B receptors in the rat brain. Eur J Pharmacol 294 2-3 (1995) 531-540
25. Boldrini M., Underwood M.D., Mann J.J., and Arango V. More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res 1041 (2005) 19-28
26. Born G.V., and Gillson R.E. Studies on the uptake of 5-hydroxy-tryptamine by blood platelets. J Physiol 146 (1959) 472-491
27. Bost R.O., and Kemp P.M. A possible association between fluoxetine use and suicide. J Anal Toxicol 16 (1992) 142-145
28. Bowers B.J., Henry M.B., Thielen R.J., and McBride W.J. Serotonin 5-HT(2) receptor stimulation of dopamine release in the posterior but not anterior nucleus accumbens of the rat. J Neurochem 75 4 (2000) 1625-1633
29. Boye S.M., Grant R.J., and Clarke P.B.S. Disruption of dopaminergic neurotransmission in nucleus accumbens core inhibits the locomotor stimulant effects of nicotine and d-amphetamine in rats. Neuropharmacology 40 (2001) 792-805
30. Briones-Aranda A., Rocha L., and Picazo O. Influence of forced swimming stress on 5-HT1A receptors and serotonin levels in mouse brain. Prog Neuropsychopharmacol Biol Psychiatry 29 (2005) 275-281
31. Caccia S. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications. Clin Pharmacokinet 34 4 (1998) 281-302
32. Carlini E.A., and Linsey C.J. Effect of serotonergic drugs on the aggressiveness induced by delta 9-tetrahydrocannabinol in rem-sleep-deprived rats. Braz J Med Biol Res 15 (1982) 281-283
33. Celada P., Puig M.V., Casanovas J.M., Guillazo G., and Artigas F. Control of dorsal raphe serotonergic neurons by the medial prefrontal cortex: involvement of serotonin-1A, GABA(A), and glutamate receptors. J Neurosci 21 24 (2001) 9917-9929
34. Chamas F.M., Underwood M.D., Arango V., Serova L., Kassir S.A., Mann J.J., et al. Immobilization stress elevates tryptophan hydroxylase mRNA and protein in the rat raphe nuclei. Biol Psychiatry 55 3 (2004) 278-283
35. Cheeta S., Tucci S., and File S.E. Antagonism of the anxiolytic effect of nicotine in the dorsal raphe nucleus by dihydro-beta-erythroidine. Pharmacol Biochem Behav 70 4 (2001) 491-496
36. Clark M.S., Sexton T.J., McClain M., Root D., Kohen R., and Neumaier J.F. Overexpression of 5-HT1B receptor in dorsal raphe nucleus using Herpes Simplex Virus gene transfer increases anxiety behavior after inescapable stress. J Neurosci 22 11 (2002) 4550-4562
37. Consolo S., Wang J.X., Forloni G.L., Mocchetti I., Racagni G., and Ladinsky H. Studies on the up regulation of alpha-adrenoceptors on rat hippocampal perikarya by chemical lesion of the median raphe nucleus. Life Sci 37 5 (1985) 449-460
38. Contreras C.M., Marvan M.L., and Muñoz-Mendez A. Clomipramine increases the responsiveness of raphe-cortical neurons in the rat. Neuropsychobiology 27 (1993) 199-203
39. Costall B., Naylor R.J., Marsden C.D., and Pycock C.J. Serotonergic modulation of the dopamine response from the nucleus accumbens. J Pharm Pharmacol 28 (1976) 523-526
40. Couch Jr. J.R. Responses of neurons in the raphe nuclei to serotonin, norepinephrine and acetylcholine and their correlation with an excitatory synaptic input. Brain Res 19 1 (1970) 137-150
41. Craven R.M., Grahame-Smith D.G., and Newberry N.R. 5-HT1A and 5-HT2 receptors differentially regulate the excitability of 5-HT-containing neurones of the guinea pig dorsal raphe nucleus in vitro. Brain Res 899 1-2 (2001) 159-168
42. Czachura J.E., and Rasmussen K. Effects of acute and chronic administration of fluoxetine on the activity of serotonergic neurons in the dorsal raphe nucleus of the rat. Naunyn-Schmiedeberg's Arch Pharmacol 362 (2000) 266-275
43. Datla K.P., and Curzon G. Behavioural and neurochemical evidence for the decrease of brain extracellular 5-HT by the antidepressant drug tianeptine. Neuropharmacology 32 9 (1993) 839-845
44. Dawson L.A., Nguyen H.Q., and Geiger A. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT-1A receptor antagonism. Neuropharmacology 38 (1999) 1153-1163
45. Day T.A., Oliver J.R., Menadue M.F., Davies B., and Willoughby J.O. Stimulatory role for medial preoptic/anterior hypothalamic area neurons in growth hormone and prolactin secretion. A kainic acid study. Brain Res 238 (1982) 55-63
46. De Souza E.B., and van Loon G.R. Brain serotonin and catecholamine responses to repeated stress in rats. Brain Res 367 (1986) 77-86
47. Dilts R.P., and Boadle-Biber M.C. Differential activation of the 5-hydroxytryptamine-containing neurons of the midbrain raphe of the rat in response to randomly presented inescapable sound. Neurosci Lett 199 (1995) 78-80
48. Di Matteo V., De Blasi A., Di Giulio C., and Esposito E. Role of 5-HT(2C) receptors in the control of central dopamine function. Trends Pharmacol Sci 22 5 (2001) 229-232
49. Di Matteo V., Cacchio M., Di Giulio C., and Esposito E. Role of serotonin-2C receptors in the control of brain dopaminergic function. Pharmacol Biochem Behav 71 (2002) 727-734
50. Dos Santos L., de Andrade T.G., and Zangrossi Jr. H. Serotonergic neurons in the median raphe nucleus regulate inhibitory avoidance but not escape behavior in the rat elevated T-maze test of anxiety. Psychopharmacology (Berl) (2004) 10.1007/s00213-004-2120-3
51. Dugast C., Souliere F., Schmitt P., Casanovas J.M., Fattaccini C.M., Mocaer E., et al. Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain?. Eur J Pharmacol 350 2-3 (1998) 171-180
52. Egan T.M., and North R.A. Acetylcholine acts on m2-muscarinic receptors to excite rat locus coeruleus neurons. Br J Pharmacol 85 4 (1985) 733-735
53. Eisenstein N., Iorio L.C., and Clody E. Role of serotonin in the blockade of muricidal behavior by tricyclic antidepressants. Pharmacol Biochem Behav 17 (1982) 847-849
54. El Mansari M., and Blier P. Functional characterization of 5-HT-1D autoreceptors on the modulation of 5-HT release in guinea-pig mesencephalic raphe hippocampus and frontal cortex. Br J Pharmacol 118 (1996) 681-689
55. El Mansari M., and Blier P. In vivo electrophysiological characterization of 5-HT receptors in the guinea pig head of caudate nucleus and orbitofrontal cortex. Neuropharmacology 36 4-5 (1997) 577-588
56. El Mansari M., Sánchez C., Chouvet G., Renaud B., and Haddjeri N. Effects of acute and long-term administration of escitalopram and citalopram on serotonin neurotransmission: an in vivo electrophysiological study in rat brain. Neuropsychopharmacology 30 7 (2005) 1269-1277
57. Ennis M., and Aston-Jones G. Two physiologically distinct populations of neurons in the ventrolateral medulla innervate the locus coeruleus. Brain Res 425 (1987) 275-282
58. Evrard A., Laporte A.M., Chastanet M., Hen R., Hamon M., and Adrien J. 5-HT1A and 5-HT1B receptors control the firing of serotonergic neurons in the dorsal raphe nucleus of the mouse: studies in 5-HT1B knock-out mice. Eur J Neurosci 11 (1999) 3823-3831
59. Feldman S., and Conforti N. The role of the medial septal nucleus in mediating adrenocortical responses to somatosensory stimulation. J Neurosci Res 5 (1980) 19-23
60. Feldman S., Conforti N., and Saphier D. Adrenal responses and neurotransmitters in posterior hypothalamic deafferentation. Brain Res Bull 25 (1990) 75-78
61. Ferraro L., Fuxe K., Tanganelli S., Fernandez M., Rambert F.A., and Antonelli T. Amplification of cortical serotonin release: a further neurochemical action of the vigilance-promoting drug modafinil. Neuropharmacology 39 11 (2000) 1974-1983
62. Ferraro L., Fuxe K., Agnati L., Tanganelli S., Tomasini M.C., and Antonelli T. Modafinil enhances the increase of extracellular serotonin levels induced by the antidepressant drugs fluoxetine and imipramine: a dual probe microdialysis study in awake rat. Synapse 55 4 (2005) 230-241
63. Fletcher P.J., and Davies M. Dorsal raphe microinjection of 5-HT and indirect 5-HT agonists induces feeding in rats. Eur J Pharmacol 184 (1990) 265-271
64. Fontes Ribeiro C.A. Pharmacology of serotonin neuronal systems. Hum Psychopharmacol Clin Exp 6 (1991) S37-S51
65. Frankenfield D.L., Baker S.P., Lange W.R., Caplan Y.H., and Smialek J.E. Fluoxetine and violent death in Maryland. Forensic Sci Int 64 (1994) 107-117
66. Frankfurt M., McKittrick C.R., and Luine V.N. Short-term fluoxetine treatment alters monoamine levels and turnover in discrete brain nuclei. Brain Res 650 1 (1994) 127-132
67. Frankfurt M., McKittrick C.R., McEwen B.S., and Luine V.N. Tianeptine treatment induces regionally specific changes in monoamines. Brain Res 696 (1995) 1-6
68. Frankhuyzen A.L., and Mulder A.H. Noradrenaline inhibits depolarization-induced 3H-serotonin release from slices of rat hippocampus. Eur J Pharmacol 63 (1980) 179-182
69. Freitas R.L., Ferreira C.M., Ribeiro S.J., Carvalho A.D., Elias-Filho D.H., Garcia-Cairasco N., et al. Intrinsic neural circuits between dorsal midbrain neurons that control fear-induced responses and seizure activity and nuclei of the pain inhibitory system elaborating postictal antinociceptive process: a functional neuroanatomical and neuropharmacological study. Exp Neurol 191 (2005) 225-242
70. Freund T.F., Gulyas A.I., Acsady L., Gorcs T., and Toth K. Serotonergic control of the hippocampus via local inhibitory interneurons. Proc Natl Acad Sci U S A 87 21 (1990) 8501-8505
71. Fuchs E., Czeh B., Michaelis T., de Biurrun G., Watanabe T., and Frahm J. Synaptic plasticity and tianeptine: structural regulation. Eur Psychiatry 17 Suppl 3 (2002) 311-317
72. Fuchs E., Czeh B., Kole M.H., Michaelis T., and Lucassen P.J. Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 14 Suppl 5 (2004) S481-S490
73. Fujino K., Yoshitake T., Inoue O., Ibii N., Kehr J., Ishida J., et al. Increased serotonin release in mice frontal cortex and hippocampus induced by acute physiological stressors. Neurosci Lett 320 (2002) 91-95
74. Fuxe K., Andersson K., Eneroth P., Siegel R.A., and Agnati L.F. Immobilization stress-induced changes in discrete hypothalamic catecholamine levels and turnover, their modulation by nicotine and relationship to neuroendocrine function. Acta Physiol Scand 117 (1983) 421-426
75. Gilbert F., Brazell C., Tricklebank M.D., and Stahl S.M. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration. Eur J Pharmacol 147 3 (1988) 431-439
76. Gobbi M., Crespi D., Foddi M.C., Fracasso C., Manzini L., Parotti L., et al. Effects of chronic treatment with fluoxetine and citalopram on 5-HT uptake, 5-HT-1B autoreceptors, 5-HT-3 and 5-HT-4 receptors in rats. Naunyn-Schmiedeberg's Arch Pharmacol 356 (1997) 22-28
77. Gorea E., and Adrien J. Serotonergic regulation of noradrenergic coerulean neurons: electrophysiological evidence for the involvement of 5-HT2 receptors. Eur J Pharmacol 154 3 (1988) 285-291
78. Grandison L., and Meites J. Evidence for adrenergic mediation of cholinergic inhibition of prolactin release. Endocrinology 99 (1976) 775-779
79. Guelfi J.D., Bouhassira M., Bonett-Perrin E., and Lancrenon S. The study of the efficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patients followed in general practice. Encephale 25 3 (1999) 265-270
80. Guyenet P.G., and Young B.S. Projections of nucleus paragigantocellularis lateralis to locus coeruleus and other structures in rat. Brain Res 406 1-2 (1987) 171-184
81. Haemisch A. Coping with social conflict, and short-term changes of plasma cortisol titers in familiar and unfamiliar environments. Physiol Behav 47 (1990) 165-1270
82. Harmer C.J., Rogers R.D., Tunbridge E., Cowen P.J., and Goodwin G.M. Tryptophan depletion decreases the recognition of fear in female. Psychopharmacology 167 (2003) 411-417
83. Hasegawa S., Watanabe A., Nishi K., Nguyen K.Q., and Diksic M. Selective 5-HT1B receptor agonist reduces serotonin synthesis following acute, and not chronic, drug administration: results of an autoradiographic study. Neurochem Int 46 3 (2005) 261-272
84. Hervas I., Bel N., Fernandez A.G., Palacios J.M., and Artigas F. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei. Naunyn-Schmiedeberg's Arch Pharmacol 358 3 (1998) 315-322
85. Hervas I., Queiroz C.M., Adell A., and Artigas F. Role of uptake inhibition and autoreceptor activation in the control of 5-HT release in the frontal cortex and dorsal hippocampus of the rat. Br J Pharmacol 30 1 (2000) 160-166
86. Hery M., Semont A., Fache M.-P., Faudon M., and Hery F. The effects of serotonin on glucocorticoid receptor binding in rat raphe nuclei and hippocampal cells in culture. J Neurochem 74 (2000) 406-413
87. Heym J., Trulson M.E., and Jacobs B.L. Effects of adrenergic drugs on raphe unit activity in freely moving cats. Eur J Pharmacol 74 2-3 (1981) 117-125
88. Hillegaart V. Effects of local application of 5-HT and 8-OH-DPAT into the dorsal and median raphe nuclei on motor activity in the rat. Physiol Behav 48 (1990) 143-148
89. Hillegaart V., and Hjorth S. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity. Eur J Pharmacol 160 2 (1989) 303-307
90. Hirschhorn I.D., Hayes R.L., and Rosecrans J.A. Discriminative control of behavior by electrical stimulation of the dorsal raphe nucleus: generalization to lysergic acid diethylamide (LSD). Brain Res 86 1 (1975) 134-138
91. Hodge G.K., and Butcher L.L. Catecholamine correlates of isolation-induced aggression in mice. Eur J Pharmacol 31 1 (1975) 81-93
92. Invernizzi R.W., and Garattini S. Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Prog Neuropsychopharmacol Biol Psychiatry 28 5 (2004) 819-827
93. Invernizzi R., Velasco C., Bramante M., Longo A., and Samanin R. Effect of 5-HT1A receptor antagonists on citalopram-induced increase in extracellular serotonin in the frontal cortex, striatum and dorsal hippocampus. Neuropharmacology 36 4-5 (1997) 467-473
94. Jacobs B., and Cohen A. Differential behavioral effects of lesions of the median and dorsal raphe nuclei in rats: open field and pain elicited aggression. J Comp Physiol Psychol 46 (1976) 102-108
95. Jacobs B.L., and Fornal C.A. 5-HT and motor control: a hypothesis. Trends Neurosci 16 9 (1993) 346-352
96. Jezova D., Tokarev D., and Rusnak M. Endogenous excitatory amino acids are involved in stress-induced adrenocorticotropin and catecholamines release. Neuroendocrinology 62 (1995) 326-332
97. Jhanwar-Uniyal M., Moorjani B., and Kahn A.H. Indications of pre- and post-synaptic 5-HT1A receptor interactions in feeding behavior and neuroendocrine regulation. Brain Res 646 2 (1994) 247-257
98. Kamoun A., Delalleau B., and Ozun M. Can a serotonin uptake agonist be an authentic antidepressant? Results of a multicenter, multinational therapeutic trial. Encephale 20 5 (1994) 521-525
99. Kant G.J., Bunnel B.N., Mougey E.H., Pennington L.L., and Meyerhoff J.L. Effects of repeated stress on pituitary cyclic AMP, and plasma prolactin, corticosterone and growth hormone in male rats. Pharmacol Biochem Behav 18 6 (1983) 967-971
100. Kelly J.P., and Leonard B.E. The effect of tianeptine and sertraline in three animal models of depression. Neuropharmacology 33 8 (1994) 1011-1016
101. Kempf E., Puglisi-Allegra S., Cabib S., Schleef C., and Mandel P. Serotonin levels and turnover in different brain areas of isolated aggressive or non-aggressive strains of mice. Prog Neuropsychopharmacol Biol Psychiatry 8 (1984) 365-371
102. Kennis L.E., Bischoff F.P., Mertens C.J., Love C.J., Van den Keybus F.A., Pieters S., et al. New 2-substituted 1,2,3,4-tetrahydrobenzofuro[3,2-c]pyridine having highly active and potent central alpha 2-antagonistic activity as potential antidepressants. Bioorg Med Chem Lett 10 1 (2000) 71-74
103. Kenny P.J., File S.E., and Neal M.J. Evidence for a complex influence of nicotinic acetylcholine receptors on hippocampal serotonin release. J Neurochem 75 6 (2000) 2409-2414
104. Key B.J., and Krzywoskinski L. Electrocortical changes induced by the perfusion of noradrenaline, acetylcholine and their antagonists directly into the dorsal raphe nucleus of the cat. Br J Pharmacol 61 2 (1977) 297-305
105. King R.A., Segman R.H., and Anderson G.M. Serotonin and suicidality: the impact of acute fluoxetine administration: I. Serotonin and suicide. Isr J Psychiatry Relat Sci 31 4 (1994) 271-279
106. Knobelman D.A., Hen R., and Lucki I. Genetic regulation of extracellular serotonin by 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) autoreceptors in different brain regions of the mouse. J Pharmacol Exp Ther 298 3 (2001) 1083-1091
107. Koe B.K., Nielsen J.A., Macor J.E., and Heym J. Biochemical and behavioral studies of the 5-HT1B receptor agonist, CP-94,253. Drug Dev Res 26 (1992) 241-250
108. Kole M.H., Swan L., and Fuchs E. The antidepressant tianeptine persistently modulates glutamate receptor currents of the hippocampal CA3 commissural associational synapse in chronically stressed rats. Eur J Neurosci 16 5 (2002) 807-816
109. Korotkova T.M., Haas H.L., and Brown R.E. Histamine excites GABAergic cells in the rat substantia nigra and ventral tegmental area in vitro. Neurosci Lett 320 3 (2002) 133-136
110. Koshikawa N., Kitamura M., Tomiyama K., and Stephenson J.D. Chronic treatment with tianeptine attenuates the behavioural effects induced by 5-HTP, but not the effects on hippocampal 5-HT concentrations. Neurosci Res Commun 22 2 (1998) 107-116
111. Kostowski W. Two noradrenergic systems in the brain and their interactions with other monoaminergic neurons. Pol J Pharmacol Pharm 31 4 (1979) 425-436
112. Kostowski W., and Plaznik A. Effect of lesions of the ventral noradrenergic bundle on the two-way avoidance behavior rats. Acta Physiol Pol 29 6 (1978) 509-514
113. Kostowski W., Czlonkowski A., Jerlicz M., Bidzinski A., and Hauptmann M. Effects of lesions of the locus coeruleus on aggressive behavior in rats. Physiol Behav 21 5 (1978) 695-699
114. Kuroda Y., Watanabe Y., and McEwen B.S. Tianeptine decreases both serotonin transporter mRNA and binding sites in rat brain. Eur J Pharmacol 268 1 (1994) R3-R5
115. Kusljic S., and van der Buuse M. Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats. Eur J Neurosci 20 12 (2004) 3424-3432
116. Kusljic S., Copolov D.L., and van den Buuse M. Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition. Neuropsychopharmacology 28 12 (2003) 2138-2147
117. Laaris N., Le Poul E., Hamon M., and Lanfumey L. Stress-induced alterations of somatodendritic 5-HT1A autoreceptor sensitivity in the rat dorsal raphe nucleus-in vitro electrophysiological evidence. Fundam Clin Pharmacol 11 (1997) 206-214
118. Lambas-Senas L., Chamba G., Fety R., and Renaud B. Comparative responses of the central adrenaline- and noradrenaline-containing neurons after reserpine injections. Biochem Pharmacol 35 13 (1986) 2207-2211
119. Lancon C., Bernard D., and Bougerol T. Fluoxetine, akathisia and suicide. Encephale 23 3 (1997) 218-223
120. Le A.D., Harding S., Juzytsch W., Fletcher P.J., and Shaham Y. The role of corticotropin-releasing factor in the median raphe nucleus in relapse to alcohol. J Neurosci 22 18 (2002) 7844-7849
121. Lechin F. Central and plasma 5-HT, vagal tone and airways. Trends Pharmacol Sci 21 (2000) 425
122. Lechin F., and van der Dijs B. Slow wave sleep (SWS), REM sleep (REMS) and depression. Res Commun Psychol Psych Behav 9 (1984) 227-262
123. Lechin F., and van der Dijs B. Platelet aggregation, platelet serotonin and pancreatitis. JOP J Pancreas 5 4 (2004) 8001-8003
124. Lechin F., and van der Dijs B. Platelet activation, and catheter intracoronary brachytherapy. Heart 90 (2004) 160-164
125. Lechin F., and van der Dijs B. Platelet serotonin and thrombostasis. J Clin Invest 113 (2004) 441-450
126. Lechin F., and van der Dijs B. Blood pressure and autonomic system assessment throughout the sleep cycle in normal adults. Sleep 28 5 (2005) 645-646
127. Lechin F., van der Dijs B., and Lechin E. Anatomic-functional correlation. In: Lechin F., van der Dijs B., and Lechin E. (Eds). The autonomic nervous system: physiological basis of psychosomatic therapy (1979), Editorial Cientifico-Medica, Barcelona, Spain 31-40
128. Lechin F., van der Dijs B., and Lechin E. Experimental basis for outlining a functional integration model of the central autonomic nervous system. In: Lechin F., van der Dijs B., and Lechin E. (Eds). The autonomic nervous system: physiological basis of psychosomatic therapy (1979), Editorial Cientifico-Medica, Barcelona, Spain 41-64
129. Lechin F., van der Dijs B., Gómez F., Arocha L., Acosta E., and Lechin E. Distal colon motility as a predictor of antidepressant response to fenfluramine, imipramine and clomipramine. J Affect Disord 5 (1983) 27-35
130. Lechin F., van der Dijs B., Jakubowicz D., Camero R.E., Villa S., Lechin E., et al. Effects of clonidine on blood pressure, noradrenaline, cortisol, growth hormone and prolactin plasma levels in low and high intestinal tone subjects. Neuroendocrinology 40 (1985) 253-261
131. Lechin F., van der Dijs B., Jakubowicz D., Camero R.E., Villa S., Arocha L., et al. Effects of clonidine on blood pressure, noradrenaline, cortisol, growth hormone, and prolactin plasma levels in high and low intestinal tone depressed patients. Neuroendocrinology 41 (1985) 156-162
132. Lechin F., van der Dijs B., Jakubowicz D., Camero R.E., Lechin S., Villa S., et al. Role of stress in the exacerbation of chronic illness. Effects of clonidine administration on blood pressure, nor-epinephrine, cortisol, growth hormone and prolactin plasma levels. Psychoneuroendocrinology 12 (1987) 117-129
133. Lechin F., van der Dijs B., Amat J., and Lechin M. Neuroanatomical basis. In: Lechin F., and van der Dijs B. (Eds). Neurochemistry and clinical disorders: circuitry of some psychiatric and psychosomatic syndromes (1989), CRC Press, Boca Raton, FL 9-12
134. Lechin F., van der Dijs B., Lechin M., Lechin-Báez S., Jara H., Lechin A., et al. Effects of an oral glucose load on plasma neurotransmitters in humans: involvement of REM sleep?. Neuropsychobiology 26 (1992) 4-11
135. Lechin F., van der Dijs B., Orozco B., Lechin M.E., Acosta E., Lechin A.E., et al. Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise conditions in major depressed patients. Biol Psychiatry 38 (1995) 166-173
136. Lechin F., van der Dijs B., Orozco B., Lechin A.E., Báez S., Lechin M.E., et al. Plasma neurotransmitters, blood pressure and heart rate during supine-resting, orthostasis and moderate exercise in dysthymic depressed patients. Biol Psychiatry 37 (1995) 884-891
137. Lechin F., van der Dijs B., and Benaim M. Stress versus depression. Prog Neuropsychopharmacol Biol Psychiatry 20 (1996) 899-950
138. Lechin F., van der Dijs B., Jara H., Orozco B., Baez S., Jahn E., et al. Plasma neurotransmitter profiles of anxiety, phobia and panic disorder patients. Acute and chronic effects of buspirone. Res Commun Psychol Psych 22 (1997) 95-110
139. Lechin F., van der Dijs B., Jara H., Orozco B., Baez S., Benaim M., et al. Effects of buspirone on plasma neurotransmitters in healthy subjects. J Neural Transm 105 6/7 (1998) 561-573
140. Lechin F., van der Dijs B., and Lechin M.E. Central neurocircuitry functioning during the wake-sleep cycle. In: Lechin F., van der Dijs B., and Lechin M.E. (Eds). Neurocircuitry and neuroautonomic disorders. Reviews and therapeutic strategies (2002), Karger, Basel 3-13
141. Lechin F., van der Dijs B., and Lechin M.E. Neuroautonomic, neuroendocrine and neuroimmune interactions. In: Lechin F., van der Dijs B., and Lechin M.E. (Eds). Neurocircuitry and neuroautonomic disorders. Reviews and therapeutic strategies (2002), Karger, Basel 57-59
142. Lechin F., van der Dijs B., and Lechin M.E. Depression. In: Lechin F., van der Dijs B., and Lechin M.E. (Eds). Neurocircuitry and neuroautonomic disorders. Reviews and therapeutic strategies (2002), Karger, Basel 23-27
143. Lechin F., van der Dijs B., Pardey-Maldonado B., Benaim M., Baez S., Orozco B., et al. Circulating neurotransmitter profiles during the different wake-sleep stages in normal subjects. Psychoneuroendocrinology 29 (2004) 669-685
144. Lechin F., van der Dijs B., Orozco B., Rodriguez S., and Baez S. Elective stenting, platelet serotonin and thrombotic events. Platelets 15 7 (2004) 462
145. Lechin F., van der Dijs B., Orozco B., Jahn E., Rodriguez S., and Baez S. Neuropharmacological treatment of refractory idiopathic thrombocytopenic purpura: roles of circulating catecholamines and serotonin. Thromb Haemost 91 (2004) 1254-1256
146. Lechin F., van der Dijs B., and Lechin A.E. The autonomic nervous system assessment throughout the wake-sleep cycle and stress. Psychosom Med 66 (2004) 974-976
147. Lechin F., van der Dijs B., Orozco B., Rodriguez S., and Baez S. Neuropharmacological therapy of polycythemia vera: roles of circulating catecholamines and serotonin. Thromb Haemost 93 (2005) 175-177
148. Lee M.D., Kennett G.A., Dourish C.T., and Clifton P.G. 5-HT1B receptors modulate components of satiety in the rat: behavioural and pharmacological analyses of the selective serotonin1B agonist CP-94,253. Psychopharmacology (Berl) 164 1 (2002) 49-60
149. Levitt P., and Moore R.Y. Origin and organization of brainstem catecholamines innervation in the rat. J Comp Neurol 186 4 (1979) 505-528
150. Lin D., and Parsons L.H. Anxiogenic-like effect of serotonin(1B) receptor stimulation in the rat elevated plus-maze. Pharmacol Biochem Behav 71 4 (2002) 581-587
151. Lindvall O., and Bjorklund A. The organization of the ascending catecholamine neuron systems in the rat brain as revealed by the glyoxylic acid fluorescence method. Acta Physiol Scand Suppl 412 (1974) 1-48
152. Lowry C.A., Rodda J.E., Lightman S.L., and Ingram C.D. Corticotropin-releasing factor increases in vitro firing rates of serotonergic neurons in the rat dorsal raphe nucleus: evidence for activation of a topographically organized mesolimbocortical serotonergic system. J Neurosci 20 20 (2000) 7728-7736
153. Lucassen P.J., Fuchs E., and Czeh B. Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 55 8 (2004) 789-796
154. Lund J.P., Kolta A., Westberg K.G., and Scott G. Brainstem mechanisms underlying feeding behaviors. Curr Opin Neurobiol 8 6 (1998) 718-724
155. Maekawa F., Tsukahara S., Tsukamura H., Maeda K.I., and Yamanouchi K. Inhibitory effect of neural transections of dorsal raphe nucleus on induction of nocturnal prolactin surge by vaginal stimulation in ovariectomized rats. Brain Res 813 1 (1998) 195-199
156. Maj J., Mogilnicka E., and Kordecka-Magiera A. Effects of chronic administration of antidepressant drugs on aggressive behavior induced by clonidine in mice. Pharmacol Biochem Behav 13 (1980) 153-154
157. Maj J., Mogilnicka E., Klimek V., and Kordecka-Magiera A. Chronic treatment with antidepressants: potentiations of clonidine-induced aggression in mice via noradrenergic mechanism. J Neural Transm 52 (1981) 189-197
158. Malagie I., Trillat A.C., Jacquot C., and Gardier A.M. Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study. Eur J Pharmacol 286 2 (1995) 213-217
159. Malagie I., Deslandes A., and Gardier A.M. Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis. Eur J Pharmacol 403 (2000) 55-65
160. Marinesco S., Poncet L., Debilly G., Jouvet M., and Cespuglio R. Effects of tianeptine, sertraline and clomipramine on brain serotonin metabolism: a voltammetric approach in the rat. Brain Res 736 (1996) 82-90
161. Martinez-Price D.L., and Geyer M.A. Subthalamic 5-HT(1A) and 5-HT(1B) receptor modulation of RU 24969-induced behavioral profile in rats. Pharmacol Biochem Behav 71 4 (2002) 569-580
162. Martin-Ruiz R., Ugedo L., Honrubia M.A., Mengod G., and Artigas F. Control of serotonergic neurons in rat brain by dopaminergic receptors outside the dorsal raphe nucleus. J Neurochem 77 (2001) 762-775
163. Marwaha J., and Aghajanian G.K. Relative potencies of alpha-1 and alpha-2 antagonists in the locus ceruleus, dorsal raphe and dorsal lateral geniculate nuclei: an electrophysiological study. J Pharmacol Exp Ther 222 2 (1982) 287-293
164. Maudhuit C., Hamon M., and Adrien J. Electrophysiological activity of raphe dorsalis serotoninergic neurones in a possible model of endogenous depression. Neuroreport 6 4 (1995) 681-684
165. Maudhuit C., Prevot E., Dangoumau L., Martin P., Hamon M., and Adrien J. Antidepressant treatment in helpless rats: effect on the electrophysiological activity of raphe dorsalis serotonergic neurons. Psychopharmacology (Berl) 130 3 (1997) 269-275
166. Mayorga A.J., Dalvi A., Page M.E., Zimov-Levinson S., Hen R., and Lucki I. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J Pharmacol Exp Ther 298 3 (2001) 1101-1107
167. McEwen B.S., and Chattarji S. Molecular mechanisms of neuroplasticity and pharmacological implications: the example of tianeptine. Eur Neuropsychopharmacol 14 Suppl 5 (2004) S497-S502
168. McQuade R., and Sharp T. Functional mapping of dorsal and median raphe 5-hydroxytryptamine pathways in forebrain of the rat using microdialysis. J Neurochem 69 2 (1997) 791-796
169. Medeiros M.A., Costa-e-Sousa R.H., Olivares E.L., Cortes W.S., and Reis L.C. A reassessment of the role of serotonergic system in the control of feeding behavior. An Acad Bras Cienc 77 1 (2005) 103-111
170. Meltzer H.Y., and Maes M. Effects of isapirone on plasma cortisol and body temperature in major depression. Biol Psychiatry 38 7 (1995) 450-457
171. Meneses A. Tianeptine: 5-HT uptake sites and 5-HT(1-7) receptors modulate memory formation in an autoshaping Pavlovian/instrumental task. Neurosci Biobehav Rev 26 (2002) 309-319
172. Mennini T., Taddei C., Codegoni A., Gobbi M., and Garattini S. Acute noise stress reduces [3H]5-hydroxytryptamine uptake in rat brain synaptosomes: protective effects of buspirone and tianeptine. Eur J Pharmacol 241 2-3 (1993) 255-260
173. Michelson D., Kociban K., Tamura R., and Morrison M.F. Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin reuptake-associated female sexual dysfunction: a randomized, placebo controlled trial. J Psychiatr Res 36 3 (2002) 147-152
174. Miczek K.A., and de Almeida R.M. Oral drug self-administration in the home cage of mice: alcohol-heightened aggression and inhibition by the 5-HT1B agonist anpirtoline. Psychopharmacology (Berl) 157 4 (2001) 421-429
175. Middlemiss D.N., and Hutson P.H. The 5-HT1B receptors. Ann N Y Acad Sci 600 (1990) 132-147
176. Miliaressis E., Bouchard A., and Jacobowitz D.M. Strong positive reward in median raphe: specific inhibition by para-chlorophenylalanine. Brain Res 98 (1975) 194-201
177. Millan M.J., Newman-Tancredi A., Audinot V., Cussac D., Lejeune F., Nicolas J.P., et al. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states. Synapse 35 2 (2000) 79-95
178. Miura H., Qiao H., Kitagami T., Ohta T., and Ozaki N. Effects of fluvoxamine on levels of dopamine, serotonin, and their metabolites in the hippocampus elicited by isolation housing and novelty stress in adult rats. Int J Neurosci 115 3 (2005) 367-378
179. Molliver M.E. Serotonergic neuronal systems: what their anatomic organization tells us about function. J Clin Psychopharmacol 7 6 Suppl (1987) 3S-23S
180. Morello H., Caligaris B., Haymal B., and Taleisnik S. Further evidence of an opposite effect of dorsal and median raphe nuclei on the proestrous surge of LH. Acta Endocrinol 122 (1990) 698-702
181. Morgane P., Stern W., and Berman E. Inihibition of unit activity in the anterior raphe by stimulation of the locus coeruleus. Anat Rec 178 (1974) 421-432
182. Morgane P.J., Galler J.R., and Mokler D.J. A review of systems and networks of the limbic forebrain/limbic midbrain. Prog Neurobiol 75 (1995) 143-160
183. Mosko S.S., and Jacobs B.L. Midbrain raphe neurons: sensitivity to glucocorticoids and ACTH in the rat. Brain Res 89 (1975) 368-375
184. Mosko S.S., and Jacobs B.L. Electrophysiological evidence against negative neuronal feedback from the forebrain controlling midbrain raphe unit activity. Brain Res 119 2 (1977) 291-303
185. Muller C.P., Carey R.J., De Souza Silva M.A., Jocham G., and Huston J.P. Cocaine increases serotonergic activity in the hippocampus and nucleus accumbens in vivo: 5-HT-1A-receptor antagonism blocks behavioral but potentiates serotonergic activation. Synapse 45 (2002) 67-77
186. Mundey M.K., Fletcher A., and Marsden C.A. Effect of the putative 5-HT1A antagonists WAY100135 and SDZ 216-525 on 5-HT neuronal firing in the guinea-pig dorsal raphe nucleus. Neuropharmacology 33 1 (1994) 61-66
187. Mundey M.K., Fletcher A., and Marsden C.A. Effects of 8-OHDPAT and 5-HT1A antagonists WAY100135 and WAY100635, on guinea-pig behaviour and dorsal raphe 5-HT neurons firing. Br J Pharmacol 117 4 (1996) 750-756
188. Newman M.E., Gur E., Dremencov E., Garcia F., Lerer B., and Van de Kar L.D. Chronic clomipramine alters presynaptic 5-HT-1B and postsynaptic 5-HT-1A receptor sensitivity in rat hypothalamus and hippocampus, respectively. Neuropharmacology 39 (2000) 2309-2317
189. Nomura M., Akama T., Alves S.E., Korach K.S., Gustafsson J.A., Pfaff D.W., et al. Differential distribution of estrogen receptor (ER)-alpha and ER-beta in the midbrain raphe nuclei and periaqueductal gray in male mouse: predominant role of ER-beta in midbrain serotonergic systems. Neuroscience 130 (2005) 445-456
190. Nowakowska E., Kus K., Chodera A., and Rybakowski J. Behavioural effects of fluoxetine and tianeptine, two antidepressants with opposite action mechanisms, in rats. Arzneimittelforschung 50 (2000) 5-10
191. O'Donohue T.L., Crowley W.R., and Jacobowitz D.M. Biochemical mapping of the noradrenergic ventral bundle projection sites: evidence for a noradrenergic-dopaminergic interaction. Brain Res 172 1 (1979) 87-100
192. Ogren S.O., Fuxe K., Agnati L.F., Gustafsson J.A., Jonsson G., and Holm A.C. Reevaluation of the indoleamine hypothesis of depression for a reduction of functional activity of central 5-HT systems by antidepressant drugs. J Neural Transm 46 (1979) 85-103
193. Owens M.J., and Nemeroff C.B. Physiology and pharmacology of corticotropin-releasing factor. Pharmacol Rev 43 (1991) 425-473
194. Owens M.J., Knight D.L., Ritchie J.C., and Nemeroff C.B. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-amino-propane stimulates the hypothalamic-pituitary-adrenal (HPA) axis: I. Acute effects on HPA axis activity and corticotropin-releasing factor-containing neurons in the rat brain. J Pharmacol Exp Ther 256 2 (1991) 787-794
195. Owens M.J., Knight D.L., Ritchie J.C., and Nemeroff CB. The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis: II. Biochemical and physiological evidence for the development of tolerance after chronic administration. J Pharmacol Exp Ther 256 2 (1991) 795-800
196. Pandey G.N., Dwivedi Y., Rizavi H.S., Ren X., Pandey S.C., Pesold C., et al. Higher expression of serotonin 5-HT(2A) receptors in the postmortem brains of teenage suicide victims. Am J Psychiatry 159 3 (2002) 419-429
197. Paris J.M., Lorens S.A., van de Kar L.D., Urban J.H., Richardson-Morton K.D., and Bethea C.L. A comparison of acute stress paradigms: hormonal responses and hypothalamic serotonin. Physiol Behav 39 1 (1987) 33-43
198. Petrov T., Krukoff T.L., and Jhamandas J.H. Branching projections of catecholaminergic brainstem neurons to the paraventricular hypothalamic nucleus and the central nucleus of the amygdala in the rat. Brain Res 609 1-2 (1993) 81-92
199. Pieribone V.A., Aston-Jones G., and Bohn M.C. Adrenergic and non-adrenergic neurons in the C1 and C3 areas project to locus coeruleus: a fluorescent double labeling study. Neurosci Lett 85 3 (1988) 297-303
200. Pies R., Shaughnessey J., and Sarango R. Putative fluoxetine-related suicidality. Can J Psychiatry 39 9 (1994) 580-581
201. Piñeyro G., and Blier P. Autoregulation of serotonin neurons: role in antidepressant drug action. Pharmacol Rev 51 3 (1999) 533-591
202. Piñeyro G., Castanon N., Hen R., and Blier P. Regulation of [3H]5-HT release in raphe, frontal cortex and hippocampus of 5-HT1B knock-out mice. Neuroreport 7 1 (1995) 353-359
203. Piñeyro G., Deveault L., de Montigny C., and Blier P. Effect of prolonged administration of tianeptine on 5-HT neurotransmission: an electrophysiological study in the rat hippocampus and dorsal raphe. Naunyn-Schmiedeberg's Arch Pharmacol 351 2 (1995) 119-125
204. Piñeyro G., Deveault L., Blier P., Dennis T., and de Montigny C. Effect of acute and prolonged tianeptine administration on the 5-HT transporter: electrophysiological, biochemical and radioligand binding studies in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 351 (1995) 111-118
205. Porras G., Di Matteo V., Fracasso C., Lucas G., De Deurwaerdere P., Caccia S., et al. 5-HT2A and 5-HT2c/2B receptor subtypes modulate dopamine release induced in vivo by amphetamine and morphine in both the rat nucleus accumbens and striatum. Neuropharmacology 26 (2002) 311-324
206. Prange-Kiel J., Rune G.M., and Leranth C. Median raphe mediates estrogenic effects to the hippocampus in female rats. Eur J Neurosci 19 2 (2004) 309-317
207. Pudovkina O.L., Cremers T.I., and Westerink B.H. The interaction between the locus coeruleus and dorsal raphe nucleus studied with dual-probe microdialysis. Eur J Pharmacol 445 1-2 (2002) 37-42
208. Puig M.V., Artigas F., and Celada P. Modulation of the activity of pyramidal neurons in rat prefrontal cortex by raphe stimulation in vivo: involvement of serotonin and GABA. Cereb Cortex 15 1 (2005) 1-14
209. Raghupathi R.K., and McGonigle P. Differential effects of the three acute stressors on the serotonin 5-HT1A receptor system in rat brain. Neuroendocrinology 65 (1997) 246-258
210. Raleigh M.J. Differential behavioral effects of tryptophan and 5-hydroxytryptophan in vervet monkeys: influence of catecholaminergic system. Psychopharmacology 93 (1987) 44-50
211. Rasmussen K., Strecker R.E., and Jacobs B.L. Single unit response of noradrenergic, serotonergic and dopaminergic neurons in freely moving cats to simple sensory stimuli. Brain Res 369 1-2 (1986) 336-340
212. Rausch J.L., Janowsky D.S., Risch S.C., and Huey L.Y. Physostigmine effects on serotonin uptake in human blood platelets. Eur J Pharmacol 109 (1985) 91-96
213. Reinhard Jr. J.F., and Roth R.R. Noradrenergic modulation of serotonin synthesis and metabolism: I. Inhibition by clonidine in vivo. J Pharmacol Exp Ther 221 (1981) 541-546
214. Reinhard J.F., Galloway M.P., and Roth R.H. Noradrenergic modulation of serotonin synthesis and metabolism: II. Stimulation by 3-Isobutyl-1-methylxanthine. J Pharmacol Exp Ther 226 (1981) 764-769
215. Renard C.E., Dailly E., Nic Dhonnchadha B.A., Hascoet M., and Bourin M. Is dopamine a limiting factor of the antidepressant-like effect in the mouse forced swimming test?. Prog Neuropsychopharmacol Biol Psychiatry 28 8 (2004) 1255-1259
216. Richter-Levin G., Greenberger V., and Segal M. The effects of general and restricted serotonergic lesions on hippocampal electrophysiology and behavior. Brain Res 642 (1994) 111-116
217. Robichaud M., and Debonnel G. Oestrogen and testosterone modulate the firing activity of dorsal raphe nucleus serotonergic neurones in both male and female rats. J Neuroendocrinol 17 3 (2005) 179-185
218. Saavedra J.M., Grobecker H., and Zivin J. Catecholamines in the raphe nuclei of the rat. Brain Res 114 2 (1976) 337-345
219. Saiz-Ruiz J., Montes J.M., Alvarez E., Cervera S., Giner J., Guerrero J., et al. Tianeptine therapy for depression in the elderly. Prog Neuropsychopharmacol Biol Psychiatry 22 2 (1998) 319-329
220. Sakai K., and Crochet S. Serotonergic dorsal raphe neurons cease firing by disfacilitation during paradoxical sleep. Neuroreport 11 14 (2000) 3237-3241
221. Sanacora G., Berman R.M., Cappiello A., Oren D.A., Kugaya A., Liu N., et al. Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response. Neuropsychopharmacology 29 6 (2004) 1166-1171
222. Saudou F., Amara D.A., Dierich A., LeMeur M., Ramboz S., Segu L., et al. Enhanced aggressive behavior in mice lacking 5-HT1B receptor. Science 265 5180 (1994) 1875-1878
223. Sawchenko P.E., Swanson L.W., Grzanna R., Howe P.R., Bloom S.R., and Polak J.M. Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus. J Comp Neurol 241 2 (1985) 138-153
224. Scheibner J., Trendelenburg A.U., Hein L., and Starke K. Alpha2-adrenoceptors modulating neuronal serotonin release: a study in alpha2-adrenoceptor subtype-deficient mice. Br J Pharmacol 132 4 (2001) 925-933
225. Schenberg L.C., and Lovick T.A. Attenuation of the midbrain-evoked defense reaction by selective stimulation of medullary raphe neurons in rats. Am J Physiol 269 (1995) R1378-R1389
226. Schlicker E., Fink K., Gothert M., Hoyer D., Molderings G., Roschke I., et al. The pharmacological properties of the presynaptic serotonin autoreceptor in the pig brain cortex conform to the 5-HT1D receptor subtype. Naunyn-Schmiedeberg's Arch Pharmacol 340 1 (1989) 45-51
227. Schreiber R., and De Vry J. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat. Eur J Pharmacol 249 3 (1993) 341-351
228. Schworer H., Racke K., and Kilbinger H. Cholinergic modulation of the release of 5-hydroxytryptamine from the guinea pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 336 (1987) 127-132
229. Scorza C., Silveira R., Nichols D.E., and Reyes-Parada M. Effects of 5-HT-releasing agents on the extracellular hippocampal 5-HT of rats. Implications for the development of novel antidepressants with a short onset of action. Neuropharmacology 38 (1999) 1055-1061
230. Serrats J., Mengod G., and Cortes R. Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei. J Chem Neuroanat 29 2 (2005) 83-91
231. Sharp T., Bramwell S.R., and Grahame-Smith D.G. Release of endogenous 5-hydroxytryptamine in rat ventral hippocampus evoked by electrical stimulation of the dorsal raphe nucleus as detected by microdialysis: sensitivity to tetrodotoxin, calcium and calcium antagonists. Neuroscience 39 3 (1990) 629-637
232. Sharp T., Umbers V., and Gartside S.E. Effect of a selective 5-HT reuptake inhibitor in combination with 5-HT1A and 5-HT1B receptor antagonists on extracellular 5-HT in rat frontal cortex in vivo. Br J Pharmacol 121 5 (1997) 941-946
233. Sheline Y.I., Mittler B.L., and Mintun M.A. The hippocampus and depression. Eur Psychiatry 17 Suppl 3 (2002) 300-305
234. Siever L.J., Kahn R.S., Lawlor B.A., Trestman R.L., Lawrence T.L., and Coccaro E.F. Critical issues in defining the role of serotonin in psychiatric disorders. Pharmacol Rev 43 (1991) 509-525
235. Sprouse J.S. Inhibition of dorsal raphe cell firing by MDL 73005EF, a novel 5-HT1A receptor ligand. Eur J Pharmacol 201 (1991) 163-169
236. Sprouse J.S., and Aghajanian G.K. Electrophysiological responses of serotoninergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonists. Synapse 1 1 (1987) 3-9
237. Sprouse J.S., and Aghajanian G.K. Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27 7 (1988) 707-715
238. Sprouse J.S., McCarty D.R., and Dudley M.W. Apparent regional differences in 5-HT-1A binding may reflect [3H]8-OH-DPAT labeling of serotonin uptake sites. Brain Res 617 (1993) 159-162
239. Sprouse J., Reynolds L., and Rollema H. Do 5-HT1B/1D autoreceptors modulate dorsal raphe cell firing? In vivo electrophysiological studies in guinea pigs with GR127935. Neuropharmacology 36 4-5 (1997) 559-567
240. Stamford J.A., Davidson C., McLaughlin D.P., and Hopwood S.E. Control of dorsal raphe 5-HT function by multiple 5-HT-1 autoreceptors: parallel purposes or pointless plurality?. Trends Neurosci 23 (2000) 459-465
241. Stamp J.A., and Semba K. Extent of colocalization of serotonin and GABA in the neurons of the rat raphe nuclei. Brain Res 677 1 (1995) 39-49
242. Strickland J.A., and Davanzo J.P. Must antidepressants be anticholinergic to inhibit muricide?. Pharmacol Biochem Behav 24 (1986) 135-137
243. Szabo S.T., and Blier P. Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus. Synapse 42 4 (2001) 203-212
244. Szabo S.T., and Blier P. Functional and pharmacological characterization of the modulatory role of serotonin on the firing activity of locus coeruleus norepinephrine neurons. Brain Res 922 1 (2001) 9-20
245. Szumlinski K.K., Frys K.A., and Kalivas P.W. Dissociable roles for the dorsal and median raphe in the facilitatory effect of 5-HT1A receptor stimulation upon cocaine-induced locomotion and sensitization. Neuropsychopharmacology 29 9 (2004) 1675-1687
246. Takahara J., Yamauchi J., Niimi M., Kajeyama J., Aoki Y., Fujino K., et al. Mechanism of prolactin release by 5-hydroxytryptophan. Life Sci 29 (1981) 1463-1466
247. Tanaka M., Matsumoto Y., Murakami T., Hisa Y., and Ibata Y. The origins of catecholaminergic innervation in the rostral ventromedial medulla oblongata of the rat. Neurosci Lett 207 (1996) 535-536
248. Tao R., and Auerbach S.B. Influence of inhibitory and excitatory inputs on serotonin efflux differs in the dorsal and median raphe nuclei. Brain Res 961 1 (2003) 109-120
249. Tassin J.P., Stinus L., Simon H., Blanc G., Thierry A.M., Le Moal M., et al. Relationship between the locomotor hyperactivity induced by A10 lesions and the destruction of the fronto-cortical dopaminergic innervation in the rat. Brain Res 141 2 (1978) 267-281
250. Thor K.B., and Helke C.J. Catecholamine-synthesizing neuronal projections to the nucleus tractus solitarii of the rat. J Comp Neurol 268 2 (1988) 264-280
251. Tizabi Y., Massari V.J., and Jacobowitz D.M. Isolation induced aggression and catecholamine variations in discrete brain areas of the mouse. Brain Res Bull 5 (1980) 81-86
252. Torterolo P., Yamuy J., Sampogna S., Morales F.R., and Chase M.H. GABAergic neurons of the cat dorsal raphe nucleus express c-fos during carbachol-induced active sleep. Brain Res 884 1-2 (2000) 68-76
253. Trulson M.E., and Frederickson C.J. A comparison of the electrophysiological and pharmacological properties of serotonin-containing neurons in the nucleus raphe dorsalis, raphe medianus and raphe pallidus recorded from mouse brain slices in vitro: role of autoreceptors. Brain Res Bull 18 2 (1987) 179-190
254. Tueth M.J. Revisiting fluoxetine (Proxac) and suicidal preoccupations. J Emerg Med 12 5 (1994) 685-687
255. Van de Kar L.D., Lorens S.A., McWilliams C.R., Kunimoto K., Urban J.H., and Bethea C.L. Role of midbrain raphe in stress-induced rennin and prolactinn secretion. Brain Res 311 (1984) 333-341
256. Vanderwolf C.H., McLauchlin M., Dringernerg H.C., and Baker G.B. Brain structures involved in the behavioral stimulant effect of central serotonin release. Brain Res 772 (1997) 121-134
257. Van Praag H.M. Depression, suicide and the metabolism of serotonin in the brain. J Affect Disord 4 (1982) 275-290
258. Vergnes M., Bandler R., and Kempf E. Muricide induced by diagonal band damage: role of 5-HT pathways. Brain Res 185 1 (1980) 203-207
259. Vertes R.P., and Kocsis B. Projections of the dorsal raphe nucleus to the brainstem: PHA-L analysis in the rat. J Comp Neurol 340 (1994) 11-26
260. Vertes R.P., and Martin G.F. Autoradiographic analysis of ascending projections from the pontine and mesencephalic reticular formation and the median raphe nucleus in the rat. J Comp Neurol 275 4 (1988) 511-541
261. Vertes R.P., Fortin W.J., and Crane A.M. Projections of the median raphe nucleus in the rat. J Comp Neurol 407 (1999) 555-582
262. Vidal C., Jordan W., and Zieglgansberger W. Cosrticosterone reduces the excitability of hippocampal pyramidal cells in vitro. Brain Res 383 (1986) 54-59
263. Waldbillig R.J. The role of the dorsal and median raphe in the inhibition of muricide. Brain Res 160 (1979) 341-346
264. Weissmann-Nanopoulos D., Mach E., Magre J., Demassey Y., and Pujol J.F. Evidence for the localization of 5-HT1A binding sites on serotonin containing neurons in the raphe dorsalis and raphe centralis nuclei of the rat brain. Neurochem Int 7 (1985) 1061-1072
265. Wilkins J.N., Carlson H.E., Van Vunakis H., Hill M.A., Gritz E., and Jarvik M.E. Nicotine from cigarette smoking increases circulating levels of cortisol, growth hormone, and prolactin in male chronic smokers. Psychopharmacology 78 (1982) 305-308
266. Wolff M., Savova M., Malleret G., Hen R., Segu L., and Buhot M.C. Serotonin 1B knockout mice exhibit a task-dependent selective learning facilitation. Neurosci Lett 338 1 (2003) 1-4
267. Xu Y., Sari Y., and Zhou F.C. Selective serotonin reuptake inhibitor disrupts organization of thalamocortical somatosensory barrels during development. Brain Res Dev Brain Res 150 2 (2004) 151-161
268. Yan Q.S., and Yan S.E. Serotonin-1B receptor-mediated inhibition of [(3)H]GABA release from rat ventral tegmental area slices. J Neurochem 79 4 (2001) 914-922
269. Yehuda R., Boisoneau D., Lowy M.T., and Giller Jr. E.L. Dose-response changes in plasma cortisol and lymphocyte glucocorticoid receptors following dexamethasone administration in combat veterans with and without posttraumatic stress disorder. Arch Gen Psychiatry 52 7 (1995) 583-593
270. Zahorodna A., Tokarski K., and Bijak M. Imipramine but not 5-HT-1A receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT-1A and 5-HT-4 receptors. Eur J Pharmacol 443 (2002) 51-57
271. Zangen A., Overstreet D.H., and Yadid G. High serotonin and 5-hydroxyindoleacetic acid levels in limbic brain regions in a rat model of depression: normalization by chronic antidepressant treatment. J Neurochem 69 6 (1997) 2477-2483